Jammu, India

Kanaya Lal Dhar

This inventor holds 3 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kanaya Lal Dhar. Retrieved from https://idiyas.com/inventor/kanaya-lal-dhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1997-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Kanaya Lal Dhar: Innovator in Pharmaceutical Chemistry**

Introduction

Kanaya Lal Dhar is an accomplished inventor based in Jammu, India, with a significant contribution to the field of pharmaceutical chemistry. He holds three patents to his name, showcasing his innovative approach to drug development and synthesis. His work focuses on enhancing the methods for preparing important medicinal compounds, demonstrating his dedication to advancing healthcare.

Latest Patents

One of Kanaya Lal Dhar's notable patents is titled "Process for Preparing Topotecan from 10-hydroxy-4-(S) camptothecin." This invention encompasses the use of dihalomethanes, specifically dichloromethane, as both a solvent and a reactant in the synthesis of Topotecan, a vital cancer treatment drug. The technique involves the rational use of solid-liquid phase transfer catalysis to effectively execute the amino-alkylation of 10-hydroxy-4-(S) camptothecin.

Another significant patent is titled "Trichosporon sp RRLY-15 (DSM 11829) and Its Use to Prepare S(+) -6-methoxy-methyl-2-naphthalene acetic acid." It introduces a novel microorganism from the genus Trichosporon sp., designated as RRLY-15, used in the production of S(+) -6-methoxy-2-naphthalene acetic acid, commonly known as Naproxen. This non-steroidal anti-inflammatory drug (NSAID) serves as an essential therapeutic agent, underscoring the practical impact of his inventions in medical applications.

Career Highlights

Kanaya Lal Dhar is affiliated with the Council of Scientific & Industrial Research (CSIR), where he has been actively involved in pioneering research within the pharmaceutical sector. His role in CSIR has provided him with a platform to collaborate with leading researchers and contribute to groundbreaking innovations aimed at solving complex healthcare challenges.

Collaborations

Throughout his career, Kanaya has collaborated with notable colleagues, including Subhash Chandra Taneja and Ghulam Nabi Qazi. These partnerships have enriched his research endeavors, enabling the fusion of diverse expertise and innovative thinking to propel forward the field of pharmaceutical chemistry.

Conclusion

Kanaya Lal Dhar stands out as a prolific inventor whose work significantly contributes to the development of critical medicinal compounds. His patents not only showcase innovation but also emphasize the importance of collaboration in scientific research. As the pharmaceutical industry continues to evolve, the contributions of inventors like Kanaya play a crucial role in ensuring advancements that positively impact global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…